NEXTGEN HEALTHCARE, INC. - Quarter Report: 2014 June (Form 10-Q)

UNITED STATES

SECURITIES and EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2014

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-12537

QUALITY SYSTEMS, INC.

(Exact name of registrant as specified in its charter)



California (State or other jurisdiction of incorporation or organization) 18111 Von Karman Avenue, Suite 700, Irvine, California (Address of principal executive offices)	95-2888568 (IRS Employer Identification No.) 92612 (Zip Code)

(949) 255-2600 (Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer þ	Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company)	Small reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

The number of outstanding shares of the Registrant’s common stock as of July 24, 2014 was 60,221,910 shares.

QUALITY SYSTEMS, INC.

TABLE OF CONTENTS

FORM 10-Q

FOR THE THREE MONTHS ENDED JUNE 30, 2014



	Item	Page

	PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements
	Unaudited Consolidated Balance Sheets as of June 30, 2014 and March 31, 2014	3
	Unaudited Consolidated Statements of Comprehensive Income for the three months ended June 30, 2014 and 2013	4
	Unaudited Consolidated Statements of Cash Flows for the three months ended June 30, 2014 and 2013	6
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures about Market Risks	36
Item 4.	Controls and Procedures	36
	PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37
Item 3.	Defaults Upon Senior Securities	37
Item 4.	Mine Safety Disclosure	37
Item 5.	Other Information	37
Item 6.	Exhibits	38
	Signatures	39

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

QUALITY SYSTEMS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)



	June 30, 2014			March 31, 2014
ASSETS
Current assets:
Cash and cash equivalents	$	107,748		$	103,145
Restricted cash	2,605			4,351
Marketable securities	8,687			10,656
Accounts receivable, net	111,842			110,181
Inventories	755			834
Income taxes receivable	5,999			8,366
Deferred income taxes, net	11,757			11,690
Other current assets	9,769			11,135
Total current assets	259,162			260,358
Equipment and improvements, net	22,915			22,801
Capitalized software costs, net	38,452			39,152
Intangibles, net	31,175			33,016
Goodwill	72,804			72,804
Other assets	17,273			16,927
Total assets	$	441,781		$	445,058

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	8,850		$	7,888
Deferred revenue	70,692			71,077
Accrued compensation and related benefits	13,894			15,953
Dividends payable	10,690			10,686
Other current liabilities	20,616			18,282
Total current liabilities	124,742			123,886
Deferred revenue, net of current	2,001			2,187
Deferred compensation	5,182			4,809
Other noncurrent liabilities	19,316			19,086
Total liabilities	151,241			149,968
Commitments and contingencies (Note 11)
Shareholders’ equity:
Common stock $0.01 par value; authorized 100,000 shares; issued and outstanding 60,222 and 60,206 shares at June 30, 2014 and March 31, 2014, respectively	602			602
Additional paid-in capital	195,733			194,739
Accumulated other comprehensive loss	(198		)	(182		)
Retained earnings	94,403			99,931
Total shareholders’ equity	290,540			295,090
Total liabilities and shareholders’ equity	$	441,781		$	445,058

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)



	Three Months Ended June 30,
	2014			2013
Revenues:
Software and hardware	$	14,743		$	15,972
Implementation and training services	6,266			6,575
System sales	21,009			22,547
Maintenance	40,805			38,608
Electronic data interchange services	18,319			16,692
Revenue cycle management and related services	16,693			16,015
Other services	21,068			15,667
Maintenance, EDI, RCM and other services	96,885			86,982
Total revenues	117,894			109,529
Cost of revenue:
Software and hardware	6,641			4,934
Implementation and training services	7,151			7,134
Total cost of system sales	13,792			12,068
Maintenance	6,914			5,302
Electronic data interchange services	11,999			10,796
Revenue cycle management and related services	12,706			11,401
Other services	10,779			8,505
Total cost of maintenance, EDI, RCM and other services	42,398			36,004
Total cost of revenue	56,190			48,072
Gross profit	61,704			61,457
Operating expenses:
Selling, general and administrative	36,730			35,096
Research and development costs	16,236			5,614
Amortization of acquired intangible assets	983			1,194
Total operating expenses	53,949			41,904
Income from operations	7,755			19,553
Interest income, net	54			31
Other income (expense), net	9			(254		)
Income before income taxes	7,818			19,330
Provision for income taxes	2,655			6,385
Net income	$	5,163		$	12,945
Other comprehensive income:
Foreign currency translation (net of $0 tax)	(8		)	(173		)
Unrealized loss on AFS securities (net of $0 tax)	(8		)	—
Comprehensive income	$	5,147		$	12,772
Net income per share:
Basic	$	0.09		$	0.22
Diluted	$	0.08		$	0.22
Weighted-average shares outstanding:
Basic	60,230			59,559
Diluted	60,770			59,572
Dividends declared per common share	$	0.175		$	0.175

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



	Three Months Ended June 30,
	2014			2013
Cash flows from operating activities:
Net income	$	5,163		$	12,945
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,136			1,897
Amortization of capitalized software costs	3,602			2,679
Amortization of other intangibles	1,841			1,866
Provision for bad debts	(1,136		)	1,805
Provision for inventory obsolescence	9			—
Share-based compensation	790			541
Deferred income taxes	16			517
Excess tax benefit from share-based compensation	—			(50		)
Change in fair value of contingent consideration	604			46
Loss on disposal of equipment and improvements	12			—
Changes in assets and liabilities:
Accounts receivable	3,172			7,503
Inventories	70			(273		)
Income taxes receivable	2,367			—
Other current assets	3,129			4,025
Other assets	(429		)	(610		)
Accounts payable	955			(4,061		)
Deferred revenue	(571		)	(2,416		)
Accrued compensation and related benefits	(2,059		)	158
Income taxes payable	(178		)	3,823
Other current liabilities	(1,568		)	149
Deferred compensation	373			141
Other noncurrent liabilities	267			842
Net cash provided by operating activities	18,565			31,527
Cash flows from investing activities:
Additions to capitalized software costs	(2,902		)	(7,300		)
Additions to equipment and improvements	(2,255		)	(1,835		)
Proceeds from sales and maturities of marketable securities	1,936			—
Net cash used in investing activities	(3,221		)	(9,135		)
Cash flows from financing activities:
Excess tax benefit from share-based compensation	—			50
Proceeds from (payments from) exercise of stock options	(54		)	250
Dividends paid	(10,687		)	(10,417		)
Payment of contingent consideration related to acquisitions	—			(62		)
Net cash used in financing activities	(10,741		)	(10,179		)
Net increase in cash and cash equivalents	4,603			12,213
Cash and cash equivalents at beginning of period	103,145			105,999
Cash and cash equivalents at end of period	$	107,748		$	118,212

QUALITY SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS – (Continued)

(In thousands)

(Unaudited)



	Three Months Ended June 30,
	2014		2013
Supplemental disclosures of cash flow information:
Cash paid during the period for income taxes, net of refunds	$	212	$	2,032

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except shares and per share data)

(Unaudited)

1. Summary of Significant Accounting Policies

Principles of Consolidation. The consolidated financial statements include the accounts of Quality Systems, Inc. and its wholly-owned subsidiaries, which consist of NextGen Healthcare Information Systems, LLC (“NextGen”), NextGen RCM Services, LLC, Opus Healthcare Solutions, LLC, ViaTrack Systems, LLC (“ViaTrack”), Matrix Management Solutions, LLC, QSI Management, LLC, Quality Systems India Healthcare Private Limited (“QSIH”) and Mirth Corporation (“Mirth”) (collectively, the “Company”). All intercompany accounts and transactions have been eliminated.

Basis of Presentation. The accompanying unaudited consolidated financial statements as of June 30, 2014 and for the three months ended June 30, 2014 and 2013 have been prepared in accordance with the requirements of Form 10-Q and Article 10 of the Securities and Exchange Commission Regulation S-X and therefore do not include all information and notes which would be presented were such consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These consolidated financial statements should be read in conjunction with the audited consolidated financial statements presented in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2014. Amounts related to disclosures of March 31, 2014 balances within these interim consolidated financial statements were derived from the aforementioned Form 10-K. In the opinion of management, the accompanying consolidated financial statements reflect all adjustments which are necessary for a fair presentation of the results of operations and cash flows for the periods presented. The results of operations for such interim periods are not necessarily indicative of results of operations to be expected for the full year.

References to amounts in the consolidated financial statement sections are in thousands, except shares and per share data, unless otherwise specified.

Revenue Recognition. The Company generates revenue from the sale of licensing rights to its software products directly to end-users and value-added resellers ("VARs"). The Company also generates revenue from sales of hardware and third-party software, implementation and training, electronic data interchange (“EDI”), revenue cycle management ("RCM"), post-contract support (maintenance) and other services, including subscriptions and hosting services, performed for clients who license the Company's products.

A typical system contract contains multiple elements of the above items. Revenue earned on software arrangements involving multiple elements is allocated to each element based on the relative fair values of those elements. The fair value of an element is based on vendor-specific objective evidence (“VSOE”). The Company limits its assessment of VSOE for each element to the price charged when the same element is sold separately. VSOE calculations are updated and reviewed quarterly or annually depending on the nature of the product or service. The Company generally establishes VSOE for the related undelivered elements based on the bell-shaped curve method. VSOE is established on maintenance for the Company's largest clients based on stated renewal rates only if the rate is determined to be substantive and falls within the Company's customary pricing practices.

When evidence of fair value exists for the delivered and undelivered elements of a transaction, discounts for individual elements are aggregated and the total discount is allocated to the individual elements in proportion to the elements' fair value relative to the total contract fair value.

When evidence of fair value exists for the undelivered elements only, the residual method is used. Under the residual method, the Company defers revenue related to the undelivered elements in a system sale based on VSOE of fair value of each of the undelivered elements and allocates the remainder of the contract price net of all discounts to revenue recognized from the delivered elements. If VSOE of fair value of any undelivered element does not exist, all revenue is deferred until VSOE of fair value of the undelivered element is established or the element has been delivered.

Provided that fees are fixed or determinable and collection is considered probable, revenue from licensing rights and sales of hardware and third-party software is generally recognized upon physical or electronic shipment and transfer of title. In certain transactions where collection risk is high, the revenue is deferred until collection occurs or becomes probable. If the fee is not fixed or determinable, then the revenue recognized in each period (subject to application of other revenue recognition criteria) will be the lesser of the aggregate amounts due and payable or the amount of the arrangement fee that would have been recognized if the fees were being recognized using the residual method. Fees which are considered fixed or determinable at the inception of the Company's arrangements must be negotiated at the outset of an arrangement and generally be based on the specific volume of products to be delivered without being subject to change based on variable pricing mechanisms such as the number of units copied or distributed or the expected number of users.

Revenue from implementation and training services is recognized as the corresponding services are performed. Maintenance revenue is recognized ratably over the contractual maintenance period.

Contract accounting is applied where services include significant modification, development or customization.

The Company ensures that the following criteria have been met prior to recognition of revenue:


▪	the price is fixed or determinable;


▪	the customer is obligated to pay and there are no contingencies surrounding the obligation or the payment;


▪	the customer's obligation would not change in the event of theft or damage to the product;


▪	the customer has economic substance;


▪	the amount of returns can be reasonably estimated; and


▪	the Company does not have significant obligations for future performance in order to bring about resale of the product by the customer.

The Company has historically offered short-term rights of return in certain sales arrangements. If the Company is able to estimate returns for these types of arrangements, revenue is recognized, net of an allowance for returns, and these arrangements are recorded in the consolidated financial statements. If the Company is unable to estimate returns for these types of arrangements, revenue is not recognized in the consolidated financial statements until the rights of return expire, provided also, that all other criteria for revenue recognition have been met.

Revenue related to sales arrangements that include hosting or the right to use software stored on the Company's hardware is recognized in accordance to the same revenue recognition criteria discussed above only if the customer has the contractual right to take possession of the software without incurring a significant penalty and it is feasible for the customer to either host the software themselves or through another third-party. Otherwise, the arrangement is accounted for as a service contract in which the entire arrangement is deferred and recognized over the period that the hosting services are being performed.

From time to time, the Company offers future purchase discounts on its products and services as part of its sales arrangements. Such discounts that are incremental to the range of discounts reflected in the pricing of the other elements of the arrangement, that are incremental to the range of discounts typically given in comparable transactions, and that are significant, are treated as an additional element of the contract to be deferred. Amounts deferred related to future purchase options are not recognized until either the customer exercises the discount offer or the offer expires.

RCM service revenue is derived from services fees, which include amounts charged for ongoing billing and other related services, and are generally billed to the customer as a percentage of total collections. The Company does not recognize revenue for services fees until these collections are made, as the services fees are not fixed or determinable until such time.

Revenue is divided into two categories, “system sales” and “maintenance, EDI, RCM and other services.” Revenue in the system sales category includes software license fees, third-party hardware and software and implementation and training services related to purchase of the Company's software systems. Revenue in the maintenance, EDI, RCM and other services category includes maintenance, EDI, RCM services, consulting services, annual third-party license fees, subscriptions, hosting services, Software as a Service ("SaaS") fees and other services revenue.

Goodwill. The Company tests goodwill for impairment annually during its first fiscal quarter, referred to as the annual test date. The Company will also test for impairment between annual test dates if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is performed at a reporting-unit level, which is defined as an operating segment or one level below an operating segment (referred to as a component). A component of an operating segment is a reporting unit if the component constitutes a business for which discrete financial information is available and segment management regularly reviews the operating results of that component.

During the quarter ended June 30, 2014, the Company elected to bypass the optional qualitative step of the goodwill impairment assessment and proceed directly with the quantitative step, under which the Company is required to compare the estimated fair value of each reporting unit with goodwill to its net carrying amount. An impairment loss is recognized when the carrying amount of the reporting unit's net assets exceeds the estimated fair value of the reporting unit. The Company determined the fair value of its reporting units utilizing the average of two valuation methods, consisting of the income approach (based upon estimates of future discounted cash flows for each reporting unit) and a market comparable approach (based upon valuation multiples of companies that operate in similar industries with similar operating characteristics). The cash flows used to determine fair value under the income approach represent Management's best estimates of projected operating results and assumed terminal growth rates that are dependent on a number of significant assumptions based on historical experience, expectations of future performance, and the expected macro-economic environment, which are subject to change given the inherent uncertainty in predicting future results. The Company also considered the Company's stock price and market capitalization as a corroborative step in assessing the reasonableness of the fair values estimated for the reporting units as part of the goodwill impairment assessment. The results of the goodwill impairment assessment established that the fair value for each reporting unit with goodwill significantly exceeded its respective net carrying amount, indicating that no goodwill impairment existed as of the annual test date.

Intangible Assets. Intangible assets consist of customer relationships, trade names and contracts and certain software technology. These intangible assets are recorded at fair value and are stated net of accumulated amortization. The Company currently amortizes the intangible assets over periods ranging from six months to nine years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed. The Company assesses the recoverability of intangible assets at least annually or whenever adverse events or changes in circumstances indicate that impairment may have occurred. If the future undiscounted cash flows expected to result from the use of the related assets are less than the carrying value of such assets, impairment has been incurred and a loss is recognized to reduce the carrying value of the intangible assets to fair value, which is determined by discounting estimated future cash flows.

Software Development Costs. Development costs, consisting primarily of employee salaries and benefits, incurred in the research and development of new software products and enhancements to existing software products for external use are expensed as incurred until

technological feasibility has been established. After technological feasibility is established, any additional external software development costs are capitalized and amortized on a straight-line basis over the estimated economic life of the related product, which is typically three years. The Company provides support services on the current and prior two versions of its software. Management performs ongoing reviews of the estimated economic life and the recoverability of such capitalized software costs. If a determination is made that capitalized amounts are not recoverable based on the estimated cash flows to be generated from the applicable software, any remaining capitalized amounts are written off.

Share-Based Compensation. The following table shows total share-based compensation expense included in the consolidated statements of comprehensive income (loss) for the three months ended June 30, 2014 and 2013:



	Three Months Ended June 30,
	2014			2013
Costs and expenses:
Cost of revenue	$	86		$	74
Research and development costs	83			42
Selling, general and administrative	621			425
Total share-based compensation	790			541
Income tax benefit	(263		)	(168		)
Decrease in net income	$	527		$	373

Recent Accounting Standards. New accounting pronouncements implemented by the Company during the current year or requiring implementation in future periods are discussed below or in the notes, where applicable.

In May 2014, the FASB, along with the International Accounting Standards Board, issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. ASU 2014-09 provides enhancements to the quality and consistency of how revenue is reported while also improving comparability in the financial statements of companies reporting using International Financial Reporting Standards and GAAP. The core principle of this updated guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new standard also requires additional disclosure about revenue and provides improved guidance for multiple element arrangements. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Companies are permitted to adopt this new guidance following either a full retrospective or modified retrospective approach. Early adoption is not permitted.

ASU 2014-09 is effective for the Company in the first quarter of fiscal 2018. The Company is currently evaluating the potential impact of implementation of this updated authoritative guidance on its consolidated financial statements.

2. Fair Value Measurements

The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at June 30, 2014 and March 31, 2014:



	Balance at		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
	June 30, 2014				Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
ASSETS
Cash and cash equivalents (1)	$	107,748	$	107,748	$	—	$	—
Restricted cash	2,605		2,605		—		—
Marketable securities (2)	8,687		8,687		—		—
	$	119,040	$	119,040	$	—	$	—
LIABILITIES
Contingent consideration related to acquisitions	$	15,517	$	—	$	—	$	15,517
	$	15,517	$	—	$	—	$	15,517



	Balance at		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
	March 31, 2014				Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)
ASSETS
Cash and cash equivalents (1)	$	103,145	$	103,145	$	—	$	—
Restricted cash	4,351		4,351		—		—
Marketable securities (2)	10,656		10,656		—		—
	$	118,152	$	118,152	$	—	$	—
LIABILITIES
Contingent consideration related to acquisitions	$	14,913	$	—	$	—	$	14,913
	$	14,913	$	—	$	—	$	14,913

___________________________________

(1) Cash and cash equivalents consists of money market funds.

(2) Marketable securities consist of fixed-income securities, including certificates of deposit and municipal securities.

The Company’s contingent consideration liability is accounted for at fair value on a recurring basis and is adjusted to fair value when the carrying value differs from fair value. The fair value adjustments are reflected as a component of selling, general and administrative expense. Key assumptions include discount rates and probability-adjusted achievement of revenue and strategic targets that are not observable in the market. The categorization of the framework used to measure fair value of the contingent consideration liability is considered Level 3 due to the subjective nature of the unobservable inputs used. The fair values of the contingent consideration liability related to the acquisitions of Sphere Health Systems, Inc., IntraNexus, Inc., and Mirth were estimated based on the probability of achieving certain business milestones and/or management’s forecast of expected revenues.

The following table presents activity in the Company’s financial assets and liabilities measured at fair value using significant unobservable inputs (Level 3), as of and for the three months ended June 30, 2014:



	Total Liabilities
Balance as of April 1, 2014	$	14,913
Fair value adjustments	604
Balance as of June 30, 2014	$	15,517

Non-Recurring Fair Value Measurements

The Company has certain assets, including goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge is recognized. The categorization of the framework used to measure fair value of the assets is considered Level 3 due to the subjective nature of the unobservable inputs used. During the three months ended June 30, 2014, there were no adjustments to fair value of such assets.

3. Goodwill

The Company does not amortize goodwill as it has been determined to have an indefinite useful life.

Goodwill by division consists of the following:



	March 31, 2014		Acquisitions		Impairment		June 30, 2014
QSI Dental Division (1)	$	7,289	$	—	$	—	$	7,289
NextGen Division	33,225		—		—		33,225
RCM Services Division	32,290		—		—		32,290
Total goodwill	$	72,804	$	—	$	—	$	72,804

(1) QSI Dental Division goodwill is presented on a basis consistent with that of the management reporting structures within QSI. For the purposes of testing goodwill for impairment annually and as otherwise may be required, however, the QSI Dental Division goodwill is allocated to all business units that derive cash flows from the products associated with the acquired goodwill. For all periods presented in this report, the allocation resulted in substantially all of such goodwill being ascribed to the NextGen Division.

Approximately 70% of the goodwill balance as of June 30, 2014 is expected to be deductible for income tax purposes over the periods prescribed by the Internal Revenue Code ("IRC").

4. Intangible Assets

The Company’s definite-lived intangible assets, other than capitalized software development costs, are summarized as follows:



	June 30, 2014
	Customer Relationships			Trade Name & Contracts			Software Technology			Total
Gross carrying amount	$	22,050		$	3,368		$	23,510		$	48,928
Accumulated amortization	(12,702		)	(1,732		)	(3,319		)	(17,753		)
Net intangible assets	$	9,348		$	1,636		$	20,191		$	31,175



	March 31, 2014
	Customer Relationships			Trade Name & Contracts			Software Technology			Total
Gross carrying amount	$	22,050		$	3,368		$	23,510		$	48,928
Accumulated amortization	(11,837		)	(1,599		)	(2,476		)	(15,912		)
Net intangible assets	$	10,213		$	1,769		$	21,034		$	33,016

Activity related to the intangible assets for the three months ended June 30, 2014 and 2013 is summarized as follows:



	Customer Relationships			Trade Name & Contracts			Software Technology			Total
Balance as of April 1, 2014	$	10,213		$	1,769		$	21,034		$	33,016
Amortization (1)	(865		)	(133		)	(843		)	(1,841		)
Balance as of June 30, 2014	$	9,348		$	1,636		$	20,191		$	31,175



	Customer Relationships			Trade Name & Contracts			Software Technology			Total
Balance as of April 1, 2013	$	13,128		$	906		$	13,516		$	27,550
Amortization (1)	(1,054		)	(80		)	(732		)	(1,866		)
Balance as of June 30, 2013	$	12,074		$	826		$	12,784		$	25,684

_______________________________

(1) Amortization of the customer relationships and the trade name & contracts intangible assets is included in operating expenses and amortization of the software technology intangible assets is included in cost of revenue for software and hardware.

The following table represents the remaining estimated amortization of definite-lived intangible assets as of June 30, 2014:



For the year ended March 31,
2015 (remaining nine months)	$	5,286
2016	7,024
2017	6,553
2018	4,301
2019	3,517
2020 and beyond	4,494
Total	$	31,175

Approximately 95% of the acquired intangible assets are expected to be deductible for income tax purposes over the periods prescribed by the IRC.

5. Capitalized Software Costs

The Company’s capitalized software development costs are summarized as follows:



	June 30, 2014			March 31, 2014
Gross carrying amount	$	103,358		$	100,455
Accumulated amortization	(64,906		)	(61,303		)
Net capitalized software costs	$	38,452		$	39,152

Activity related to net capitalized software costs for the three months ended June 30, 2014 and 2013 is summarized as follows:



	2014			2013
Balance as of April 1	$	39,152		$	39,781
Capitalized	2,902			7,300
Amortization	(3,602		)	(2,679		)
Balance as of June 30	$	38,452		$	44,402

The following table presents the remaining estimated amortization of capitalized software costs as of June 30, 2014. The estimated amortization is comprised of (i) amortization of released products and (ii) the expected amortization for products that are not yet available for sale based on their estimated economic lives and projected general release dates.



For the year ended March 31,
2015 (remaining nine months)	$	11,500
2016	13,800
2017	6,700
2018	2,900
2019	2,700
2020 and beyond	852
Total	$	38,452

6. Composition of Certain Financial Statement Captions

Accounts receivable include amounts related to maintenance and services that were billed but not yet rendered at each period end. Undelivered maintenance and services are included as a component of the deferred revenue balance on the accompanying consolidated balance sheets.



	June 30, 2014			March 31, 2014
Accounts receivable, gross	$	127,476		$	127,006
Sales return reserve	(10,774		)	(10,530		)
Allowance for doubtful accounts	(4,860		)	(6,295		)
Accounts receivable, net	$	111,842		$	110,181

Inventories are summarized as follows:



	June 30, 2014		March 31, 2014
Computer systems and components	$	755	$	834

Equipment and improvements are summarized as follows:



	June 30, 2014			March 31, 2014
Computer equipment	$	38,273		$	37,322
Furniture and fixtures	9,571			9,395
Leasehold improvements	9,934			8,874
	57,778			55,591
Accumulated depreciation and amortization	(34,863		)	(32,790		)
Equipment and improvements, net	$	22,915		$	22,801

Current and non-current deferred revenue are summarized as follows:



	June 30, 2014		March 31, 2014
Maintenance	$	14,942	$	15,482
Implementation services	34,149		36,634
Annual license services	11,351		11,176
Undelivered software and other (1)	10,250		7,785
Deferred revenue	$	70,692	$	71,077
Deferred revenue, net of current	$	2,001	$	2,187

(1) Includes subscriptions and SaaS deferred revenue.

Accrued compensation and related benefits are summarized as follows:



	June 30, 2014		March 31, 2014
Payroll, bonus and commission	$	3,473	$	6,193
Vacation	10,421		9,760
Accrued compensation and related benefits	$	13,894	$	15,953

Other current and non-current liabilities are summarized as follows:



	June 30, 2014		March 31, 2014
Customer deposits and liabilities	$	3,699	$	76
Self insurance reserve	2,675		2,090
Care services liabilities	2,605		4,351
Accrued EDI expense	1,978		1,702
Accrued royalties	1,423		1,418
Accrued consulting	1,311		1,707
Contingent consideration and other liabilities related to acquisitions	978		1,052
Deferred rent	843		964
Users group meeting deposits	549		—
Professional services	303		170
Accrued travel	251		369
Outside commission payable	144		255
Other accrued expenses	3,857		4,128
Other current liabilities	$	20,616	$	18,282

Contingent consideration and other liabilities related to acquisitions	$	15,030	$	14,736
Deferred rent	3,482		3,509
Income tax payable	804		841
Other non-current liabilities	$	19,316	$	19,086

7. Income Taxes

The provision for income taxes for the three months ended June 30, 2014 and 2013 was approximately $2.7 million and $6.4 million, respectively. The effective tax rates were 34.0% and 33.0% for the three months ended June 30, 2014 and 2013, respectively. The effective rate for the three months ended June 30, 2014 increased as compared to the same prior year period primarily due to the absence of a federal research and development tax credit reflected in the current period, offset by an increased benefit of the foreign rate differential and a decrease in qualified production activities deduction. The federal research and development tax credit statute expired on December 31, 2013 and has not been reenacted as of June 30, 2014.

The deferred tax assets and liabilities have been shown net in the accompanying consolidated balance sheets based on the long-term or short-term nature of the items that give rise to the deferred amount. The Company expects to receive the full benefit of the deferred tax assets recorded with the exception of a specific state tax credit for which the Company has recorded a valuation allowance.

Uncertain tax positions As of June 30, 2014, the Company had recorded a liability of $759 for unrecognized tax benefits related to various federal, state and local income tax matters. If recognized, this amount would reduce the Company’s effective tax rate. The tax liability for the three months ended June 30, 2014 increased from the same prior year period by $24 due to changes in reserves for state and local income tax liabilities and certain tax positions related to acquired companies.

The Company is no longer subject to U.S. federal income tax examinations for tax years before 2013. With few exceptions, the Company is no longer subject to state income tax examinations for tax years before 2009. The Company does not anticipate that total unrecognized tax benefits will significantly change due to the settlement of audits or the expiration of statute of limitations within the next twelve months.

8. Earnings per Share

The Company provides presentation of “basic” and “diluted” earnings per share (“EPS”). Shares discussed below are in thousands.



	Three Months Ended June 30,
	2014		2013
Net income	$	5,163	$	12,945
Basic net income per share:
Weighted-average shares outstanding — Basic	60,230		59,559
Basic net income per common share	$	0.09	$	0.22

Net income	$	5,163	$	12,945
Diluted net income per share:
Weighted-average shares outstanding — Basic	60,230		59,559
Effect of potentially dilutive securities	540		13
Weighted-average shares outstanding — Diluted	60,770		59,572
Diluted net income per common share	$	0.08	$	0.22

The computation of diluted net income per share does not include 1,492 and 1,227 options to acquire shares of common stock for the three months ended June 30, 2014 and 2013, respectively, because their inclusion would have an anti-dilutive effect on net income per share.

9. Share-Based Awards

Employee Stock Option and Incentive Plans

In September 1998, the Company’s shareholders approved a stock option plan (the “1998 Plan”) under which 8,000,000 shares of common stock were reserved for the issuance of options. The 1998 Plan provides that employees and directors of the Company may, at the discretion of the Board of Directors or a duly designated compensation committee, be granted options to purchase shares of common stock. The exercise price of each option granted was determined based on the date of grant, and options under the 1998 Plan expire no later than 10 years from the date of grant. Options granted pursuant to the 1998 Plan became exercisable in accordance with the terms of the agreements pursuant to which they were granted. Upon change of control of the Company, as such term is defined in the 1998 Plan, each outstanding option may be subject to accelerated vesting at the discretion of the Board of Directors if no provision is made for the continuance of the 1998 Plan and the assumption of the options outstanding under the 1998 Plan, or certain other circumstances. The 1998 Plan was terminated on December 31, 2007. As of June 30, 2014, there were 20,000 outstanding options related to the 1998 Plan.

In October 2005, the Company’s shareholders approved a stock option and incentive plan (the “2005 Plan”) under which 4,800,000 shares of common stock were reserved for the issuance of awards, including incentive stock options and non-qualified stock options, stock appreciation rights, restricted stock, unrestricted stock, restricted stock units, performance shares, performance units (including performance options) and other share-based awards. The 2005 Plan provides that employees and directors of the Company may, at the discretion of the Board of Directors or a duly designated compensation committee, be granted certain share-based awards. In the case of option awards granted under the 2005 Plan, the exercise price of each option is determined based on the date of grant and expire no later than 10 years from the date of grant. Awards granted pursuant to the 2005 Plan are subject to the vesting schedule or performance metrics set forth in the agreements pursuant to which they are granted. Upon a change of control of the Company, as such term is defined in the 2005 Plan, awards under the 2005 Plan will fully vest under certain circumstances. The 2005 Plan expires on May 25, 2015, unless terminated earlier by the Board of Directors. As of June 30, 2014, there were 1,759,551 outstanding options, 53,293 outstanding shares of restricted stock, restricted stock units and performance based restricted stock, and 2,222,739 shares available for future grant under the 2005 Plan.

A summary of stock option transactions during the three months ended June 30, 2014 follows:



	Number of Shares		Weighted- Average Exercise Price per Share		Weighted- Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding, April 1, 2014	1,370,101		$	27.85	5.8
Granted	439,650		15.99		7.9
Exercised	—		—		0	$	—
Forfeited/Canceled	(30,200	)	26.24		6.3
Outstanding, June 30, 2014	1,779,551		$	24.94	6.1	$	26
Vested and expected to vest, June 30, 2014	1,678,763		$	25.12	6.1	$	24
Exercisable, June 30, 2014	571,981		$	30.90	4.7	$	—

The Company utilizes the Black-Scholes valuation model for estimating the fair value of share-based compensation with the following assumptions:



	Three Months Ended June 30, 2014	Three Months Ended June 30, 2013
Expected life	4.8 years	4.9 years
Expected volatility	36.6%	43.7%
Expected dividends	4.3%	3.9%
Risk-free rate	1.7%	1.0%

The weighted-average grant date fair value of stock options granted during the three months ended June 30, 2014 and 2013 was $3.50 and $4.87 per share, respectively.

The Company issues new shares to satisfy option exercises. Based on historical experience of option cancellations, the Company has estimated an annualized forfeiture rate of 8.4% and 8.1% for employee options for the three months ended June 30, 2014 and 2013, respectively, and 0.0% for director options for the three months ended June 30, 2014 and 2013. Forfeiture rates are adjusted over the requisite service period when actual forfeitures differ, or are expected to differ, from the estimate.

During the three months ended June 30, 2014, a total of 439,650 options to purchase shares of common stock were granted under the 2005 Plan at an exercise price equal to the market price of the Company’s common stock on the date of grant. A summary of stock options granted under the 2005 Plan during fiscal years 2015 and 2014 is as follows:



Option Grant Date	Number of Shares	Exercise Price		Vesting Terms (1)	Expires
June 3, 2014	439,650	$	15.99	Five years	June 3, 2022
Fiscal year 2015 option grants	439,650

August 15, 2013	85,000	$	20.85	Five years	August 15, 2021
July 30, 2013	28,000	$	22.59	Five years	July 30, 2021
May 29, 2013	356,000	$	17.95	Five years	May 29, 2021
Fiscal year 2014 option grants	469,000

__________________________________

(1) Options vest in equal annual installments on each grant anniversary date commencing one year following the date of grant.

Employee and Executive Officer Awards

On May 28, 2014, the Board of Directors awarded options to purchase the Company’s common stock to certain high-performing employees. The options were granted on the first day of the next open trading window under the Company's Insider Trading Policy, issued pursuant to the 2005 Plan, have an exercise price equal to the closing price of the Company’s shares on the date of grant, a term of eight years and vest in five equal annual installments commencing one year following the date of grant.

On May 27, 2014, the Compensation Committee of the Board of Directors approved the Company's fiscal year 2015 Executive Compensation Program (the "Program") under which the Company's named executive officers are eligible to receive cash bonuses based on meeting certain target increases in revenue and non-GAAP financial targets, as defined in the Program (i.e. non-GAAP earnings per share and a measure of free cash flow) for fiscal year 2015. Under the Program, the named executive officers also received certain equity incentive awards issued under the 2005 Plan. These equity awards included (i) an aggregate of 105,000 options to purchase the Company's common stock, which were granted on the first day of the next open trading window under the Company's Insider Trading Policy, have an exercise price equal to the closing price of the Company's shares on the date of grant, a term of eight years and a vesting schedule of five equal annual installments commencing one year following the date of grant; and (ii) a potential award of up to an aggregate of 170,000 restricted performance shares of the Company's common stock vesting over a three year period based on the achievement of target average daily share prices for the ninety calendar day period ending May 31st of each of the subsequent three fiscal years.

Share-based compensation expense associated with the restricted performance shares under the Program is based on the grant date fair value measured at the underlying closing share price on the date of grant using a Monte Carlo-based valuation model. Share-based compensation expense associated with the options under the Company’s equity incentive programs are initially based on the number of options expected to vest after assessing the probability that the performance criteria will be met. Cumulative adjustments are recorded quarterly to reflect subsequent changes in the estimated outcome of performance-related conditions. The Company utilizes the Black-Scholes option valuation model with the assumptions in the table below to calculate the share-based compensation expense related to the options. Share-based compensation expense recorded for these performance-based awards was $104 and $92 for the three months ended June 30, 2014 and 2013, respectively.



	Three Months Ended June 30, 2014	Three Months Ended June 30, 2013
Expected life	4.8 years	4.9 years
Expected volatility	36.5%	43.5%
Expected dividends	4.3%	3.7%
Risk-free rate	1.6%	1.4%

Non-vested stock option award activity, including employee stock options and performance-based awards, during the three months ended June 30, 2014 is summarized as follows:



	Non-Vested Number of Shares		Weighted- Average Grant-Date Fair Value per Share
Outstanding, April 1, 2014	991,560		$	7.73
Granted	439,650		3.50
Vested	(193,440	)	8.50
Forfeited/Canceled	(30,200	)	7.66
Outstanding, June 30, 2014	1,207,570		$	6.07

As of June 30, 2014, $6,308 of total unrecognized compensation costs related to stock options is expected to be recognized over a weighted-average period of 3.8 years. This amount does not include the cost of new options that may be granted in future periods or any changes in the Company’s forfeiture percentage. The total fair value of options vested during the three months ended June 30, 2014 and 2013 was $1,645 and $1,057, respectively.

Director Awards

On May 28, 2014, the Board of Directors approved its 2015 Director Compensation Program, pursuant to which each non-employee director is to be granted shares of restricted stock upon election or re-election to the Board of Directors. The shares of restricted stock are awarded under the 2005 Plan. Such shares of restricted stock vest in two equal, annual installments on the first and second anniversaries of the grant date and are nontransferable for one year following vesting. The weighted-average grant date fair value for the restricted stock was estimated using the market price of the common stock on the date of grant. The fair value of the restricted stock is amortized on a straight-line basis over the vesting period.

The Company recorded compensation expense related to restricted stock of approximately $174 and $92 for the three months ended June 30, 2014 and 2013, respectively. Restricted stock activity for the three months ended June 30, 2014 is summarized as follows:



	Number of Shares		Weighted- Average Grant-Date Fair Value per Share
Outstanding, April 1, 2014	64,571		$	20.74
Granted	788		17.14
Vested	(12,066	)	21.68
Outstanding, June 30, 2014	53,293		$	21.21

As of June 30, 2014, $713 of total unrecognized compensation costs related to restricted stock is expected to be recognized over a weighted-average period of 1.1 years. This amount does not include the cost of new restricted stock that may be granted in future periods.

10. Concentration of Credit Risk

The Company had cash deposits at U.S. banks and financial institutions which exceeded federally insured limits at June 30, 2014. The Company is exposed to credit loss for amounts in excess of insured limits in the event of non-performance by the institutions; however, the Company does not anticipate non-performance by these institutions.

11. Commitments, Guarantees and Contingencies

Commitments and Guarantees

The Company's software license agreements include a performance guarantee that the Company's software products will substantially operate as described in the applicable program documentation for a period of 365 days after delivery. To date, the Company has not incurred any significant costs associated with its performance guarantee or other related warranties and does not expect to incur significant warranty costs in the future. Therefore, no accrual has been made for potential costs associated with these warranties. Certain arrangements also include performance guarantees related to response time, availability for operational use, and other performance-related guarantees. Certain arrangements also include penalties in the form of maintenance credits should the performance of the software fail to meet the performance guarantees. To date, the Company has not incurred any significant costs associated with these warranties and does not expect to incur significant warranty costs in the future. Therefore, no accrual has been made for potential costs associated with these warranties.

The Company has historically offered short-term rights of return in certain sales arrangements. If the Company is able to estimate returns for these types of arrangements and all other criteria for revenue recognition have been met, revenue is recognized and these arrangements are recorded in the consolidated financial statements. If the Company is unable to estimate returns for these types of arrangements, revenue is not recognized in the consolidated financial statements until the rights of return expire, provided also, that all other criteria of revenue recognition have been met.

Certain standard sales agreements contain a money back guarantee providing for a performance guarantee that is already part of the software license agreement as well as training and support. The money back guarantee also warrants that the software will remain robust and flexible to allow participation in the federal health incentive programs. The specific elements of the performance guarantee pertain to aspects of the software, which the Company has already tested and confirmed to consistently meet using the Company's existing software without any modifications or enhancements. To date, the Company has not incurred any costs associated with this guarantee and does not expect to incur significant costs in the future. Therefore, no accrual has been made for potential costs associated with this guarantee.

The Company's standard sales agreements contain an indemnification provision pursuant to which it shall indemnify, hold harmless, and reimburse the indemnified party for losses suffered or incurred by the indemnified party in connection with any United States patent, any copyright or other intellectual property infringement claim by any third-party with respect to its software. As the Company has not incurred any significant costs to defend lawsuits or settle claims related to these indemnification agreements, the Company believes that its estimated exposure on these agreements is currently minimal. Accordingly, the Company has no liabilities recorded for these indemnification obligations.

Hussein Litigation

On October 7, 2013, a complaint was filed against the Company and certain of the Company’s officers and directors in the Superior Court of the State of California for the County of Orange, captioned Ahmed D. Hussein v. Sheldon Razin, Steven Plochocki, Quality Systems, Inc. and Does 1-10, inclusive, No. 30-2013-00679600-CU-NP-CJC, by Ahmed Hussein, a former director and significant shareholder of the Company. The Company filed a demurrer to the complaint, which the Court granted on April 10, 2014. An amended complaint was filed on April 25, 2014. The amended complaint generally alleges fraud and deceit, constructive fraud, negligent misrepresentation and breach of fiduciary duty in connection with statements made to the Company’s shareholders regarding the Company’s financial condition and projected future performance. The amended complaint seeks actual damages, exemplary and punitive damages and costs. The Company has filed a demurrer to the amended

complaint and is awaiting a decision from the Court. The Company believes that plaintiff’s claims are without merit and continues to defend against them vigorously.

Federal Securities Class Action

On November 19, 2013, a putative class action complaint was filed on behalf of the shareholders of the Company other than the defendants against the Company and certain of the Company’s officers and directors in the United States District Court for the Central District of California, captioned Deerfield Beach Police Pension Fund, individually and on behalf of all others similarly situated, v. Quality Systems, Inc., Steven T. Plochocki, Paul A. Holt and Sheldon Razin, No. SACV13-01818-CJC-JPRx, by the Deerfield Beach Police Pension Fund, a shareholder of the Company. After the court appointed lead plaintiffs and lead counsel for this action, lead plaintiffs filed an amended complaint on April 7, 2014. The amended complaint, which is substantially similar to the litigation described above under the caption “Hussein Litigation,” generally alleges that statements made to the Company’s shareholders regarding the Company’s financial condition and projected future performance were false and misleading in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the individual defendants are liable for such statements because they are controlling persons under Section 20(a) of the Exchange Act. The complaint seeks compensatory damages, court costs and attorneys' fees. The Company filed a motion to dismiss the amended complaint on June 20, 2014. The Company believes that plaintiff’s claims are without merit and intends to defend against them vigorously.

Shareholder Derivative Litigation

On January 24, 2014, a complaint was filed against the Company and certain of the Company’s officers and current and former directors in the United States District Court for the Central District of California, captioned Timothy J. Foss, derivatively on behalf of himself and all others similarly situated, vs. Craig A. Barbarosh, George H. Bristol, James C. Malone, Peter M. Neupert, Morris Panner, D. Russell Pflueger, Steven T. Plochocki, Sheldon Razin, Lance E. Rosenzweig and Quality Systems, Inc., No. SACV14-00110-DOC-JPPx, by Timothy J. Foss, a shareholder of the Company. The complaint arises from the same allegations described above under the captions “Hussein Litigation” and “Federal Securities Class Action” and generally alleges breach of fiduciary duties, abuse of control and gross mismanagement by the Company’s directors, in addition to unjust enrichment and insider selling by individual directors. The complaint seeks compensatory damages, restitution and disgorgement of all profits, court costs, attorneys’ fees and implementation of enhanced corporate governance procedures. The parties have agreed to stay this litigation pending resolution of the Defendants' anticipated motion to dismiss the Federal Securities Class Action. The Company believes that plaintiff’s claims are without merit and intends to defend against them vigorously.

12. Operating Segment Information

The Company has four reportable segments that are evaluated regularly by its chief decision making group (consisting of the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer) in deciding how to allocate resources and in assessing performance. The chief decision making group evaluates performance based upon stand-alone segment operating income. Since assets by segment are not reported to or used by the Company’s chief decision making group to allocate resources, or to assess performance, total assets by segment are not disclosed.

Operating segment data is as follows:



	Three Months Ended June 30,
	2014			2013
Revenue:
QSI Dental Division	$	4,243		$	5,151
NextGen Division	91,714			81,535
Hospital Solutions Division	4,176			5,467
RCM Services Division	17,761			17,376
Consolidated revenue	$	117,894		$	109,529

Operating income (loss):
QSI Dental Division	$	935		$	1,641
NextGen Division	43,965			36,629
Hospital Solutions Division	(1,125		)	(704		)
RCM Services Division	1,836			3,022
Corporate and unallocated	(37,856		)	(21,035		)
Consolidated operating income	$	7,755		$	19,553

Effective April 1, 2014, the Company refined the measurement of its segment data to better reflect an organizational structure whereby certain expenses managed by functional area leadership are no longer classified within the operating segments but rather as a component of Corporate and unallocated. Such classification is consistent with the disaggregated financial information used by the Company's chief decision making group. The amounts classified as Corporate and unallocated have historically consisted primarily of corporate general and administrative costs and other centrally managed overhead costs, including accounting and finance, human resources, and legal costs, as well as non-recurring acquisition costs and the post-acquisition amortization of certain intangible assets. Currently, as a result of the refinement of its segment data, the Company no longer classifies the costs of the marketing and research and development functional areas and the amortization of capitalized software costs within the operating segments. The Company has retroactively reclassified the prior year operating income in the table above to present all segment information on a comparable basis.

The major components of the Corporate and unallocated amounts are summarized in the table below:



	Three Months Ended June 30,
	2014		2013
Research and development costs	$	16,236	$	5,614
Amortization of capitalized software costs	4,491		2,395
Marketing expense	3,229		2,167
Other Corporate and overhead costs	13,900		10,859

Total Corporate and unallocated	37,856		21,035

13. Subsequent Events

On July 23, 2014, the Board of Directors approved a quarterly cash dividend of $0.175 per share on the Company’s outstanding shares of common stock, payable to shareholders of record as of September 12, 2014 with an expected distribution date on or about October 3, 2014.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and certain information incorporated herein by reference contain forward-looking statements within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements included or incorporated by reference in this Quarterly Report on Form 10-Q, other than statements that are purely historical, are forward-looking statements. Words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “should,” “would,” “could,” “may,” and similar expressions also identify forward-looking statements. These forward-looking statements include, without limitation, discussions of our product development plans, business strategies, future operations, financial condition and prospects, developments in and the impacts of government regulation and legislation, including, without limitation, The American Recovery and Reinvestment Act ("ARRA") and The Patient Protection and Affordable Care Act, and market factors influencing our results. Our expectations, beliefs, objectives, intentions and strategies regarding our future results are not guarantees of future performance and are subject to risks and uncertainties, both foreseen and unforeseen, that could cause actual results to differ materially from results contemplated in our forward-looking statements. These risks and uncertainties include, but are not limited to, our ability to continue to develop new products and increase systems sales in markets characterized by rapid technological evolution, consolidation, and competition from larger, better-capitalized competitors. Many other economic, competitive, governmental and technological factors could affect our ability to achieve our goals, and interested persons are urged to review any risks that may be described in “Item 1A. Risk Factors” as set forth herein and other risk factors appearing in our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2014 (“Annual Report”), as supplemented by additional risk factors, if any, in our interim filings on our Quarterly Reports on Form 10-Q, as well as in our other public disclosures and filings with the Securities and Exchange Commission ("SEC"). Because of these risk factors, as well as other variables affecting our financial condition and results of operations, past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods. We assume no obligation to update any forward-looking statements. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of the filing of this Quarterly Report on Form 10-Q.

This management's discussion and analysis of financial condition and results of operations ("MD&A") is provided as a supplement to the consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q in order to enhance your understanding of our results of operations and financial condition and should be read in conjunction with, and is qualified in its entirety by, the consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Historical results of operations, percentage margin fluctuations and any trends that may be inferred from the discussion below are not necessarily indicative of the operating results for any future period.

Our MD&A is organized as follows:


•	Management Overview. This section provides a general description of our Company and operating segments, a discussion as to how we derive our revenue, background information on certain trends and developments affecting our Company and a discussion on management’s strategy for driving revenue growth.

•

Critical Accounting Policies and Estimates. This section discusses those accounting policies that are considered important to the evaluation and reporting of our financial condition and results of operations, and whose application requires us to exercise subjective or complex judgments in making estimates and assumptions. In addition, all of our significant accounting policies, including our critical accounting policies, are summarized in Note 1, “Summary of Significant Accounting Policies,” of our notes to consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.


•	Company Overview. This section provides a more detailed description of our Company, its operating segments, a summary of our acquisition transactions and the products and services we offer.


•	Overview of Results of Operations and Results of Operations by Operating Divisions. These sections provide our analysis and outlook for the significant line items on our consolidated statements of income, as well as other information that we deem meaningful to understand our results of operations on both a consolidated basis and an operating division basis.


•	Liquidity and Capital Resources. This section provides an analysis of our liquidity and cash flows.


•	New Accounting Pronouncements. This section provides a summary of the most recent authoritative accounting standards and guidance that have either been recently adopted by our Company or may be adopted in the future.

Management Overview

Quality Systems, Inc. and its wholly-owned subsidiaries operate as four business divisions (each, a "Division") which are comprised of: (i) the QSI Dental Division, (ii) the NextGen Division, (iii) the Hospital Solutions Division and (iv) the RCM Services Division. We also have a captive entity in India called Quality Systems India Healthcare Private Limited (“QSIH”). We primarily derive revenue by developing and marketing healthcare information systems that automate certain aspects of medical and dental practices, networks of practices such as physician hospital organizations (“PHOs”) and management service organizations (“MSOs”), ambulatory care centers, community health centers and medical and dental schools along with comprehensive systems implementation, maintenance and support and add on complementary services such as revenue cycle management (“RCM”) and electronic data interchange (“EDI”). Our systems and services provide our clients with the ability to redesign patient care and other workflow processes while improving productivity through the facilitation of managed access to patient information. Utilizing our proprietary software in combination with third-party hardware and software solutions, our products enable the integration of a variety of administrative and clinical information operations. Our scalable interoperability and population health offerings help to improve care collaboration, quality and safety. Enabled by our interoperability solutions, data-driven patient population healthcare management decisions assist in creating more desirable operational, clinical, and financial outcomes that substantiate the value of patient-centered and accountable care models.

The turbulence in the worldwide economy has impacted almost all industries. While healthcare is not immune to economic cycles, we believe it is more heavily influenced by US-based regulatory and national health projects than by the economic cycles of our economy. The impact of the current economic conditions on our existing and prospective clients has been mixed. While we continue to see organizations that are doing fairly well operationally, some organizations, especially those with a large dependency on Medicaid populations, have been impacted by the challenging financial conditions faced by many state governments. Various factors have had, and are anticipated to continue to have, a meaningful impact on the U.S. healthcare industry, including the Obama Administration's broad healthcare reform efforts (particularly the HITECH portion of the American Recovery and Reinvestment Act ("ARRA") and the Patient Protection and Affordable Care Act), the mandate requiring individuals to obtain insurance, the individual state responses to the government-requested Medicaid expansion, the creation and operation of insurance exchanges, and the increasing focus of private businesses on moving their employee health benefit offerings to a more wellness-based health platform.

We have benefited and hope to continue to benefit from the increased demands on healthcare providers for greater efficiency and lower costs, financial incentives from the ARRA to physicians who adopt electronic health records, as well as increased adoption rates for electronic health records and other technology in the healthcare arena. We also believe that healthcare reform and the movement towards pay for performance/quality initiatives will also stimulate demand for robust electronic health record solutions as well as new health information technology solutions from bundled billing capabilities to patient engagement and population health management.

While we expect to benefit from the increasing demands for greater efficiency as well as government support for increased adoption of electronic health records, the market for physician based electronic health records software is becoming increasingly saturated while physician group practices are rapidly being consolidated by hospital, insurance payers and other entities. Hospital software providers are leveraging their position with their hospital customers to gain market share with hospital owned physician practices. Insurance providers and large physician groups are also consolidating physician offices creating additional opportunity for ambulatory software providers like us. Our strategy is to focus on addressing the growing needs of accountable care organizations around interoperability, patient engagements, population health, and data analytics.

We believe that our core strength lies in the central role our software products and services play in the delivery of healthcare by the primary physician in an ambulatory setting. We intend to remain at the forefront of upcoming new regulatory requirements including ICD-10 and meaningful use requirements for stimulus payments. We believe that the expanded requirements for continued eligibility for incentive payments under meaningful use rules will result in an expanded replacement market for electronic health records software. We intend to continue the development and enhancement of our software solutions to support healthcare reform and the transition from fee for service to pay for performance/quality initiatives such as accountable care organizations. Key elements of our future software development will be to expand our interoperability capabilities enhancing the competitiveness of our software offerings, continue to integrate our ambulatory and hospital products, make our products more intuitive and easy to use, and to enhance our ability to deliver our software over the cloud with the latest technology.

We also want to continue investments in our infrastructure, including but not limited to adding new clients through maintaining and expanding sales, marketing and product development activities and expanding our relationship with existing clients through delivery of add-on and complementary products and services while continuing our gold-standard commitment of service in support of our client satisfaction programs. These investments in our infrastructure will continue while maintaining reasonable expense discipline. We believe that our growing customer base that is using our software on a daily basis is a strategic asset, and we intend to leverage this strategic asset by expanding our product and service offerings towards this customer base.

Critical Accounting Policies and Estimates

The discussion and analysis of our consolidated financial statements and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate estimates (including but not limited to those related to revenue recognition, uncollectible accounts receivable, capitalizable software development costs, intangible assets and self-

insurance accruals) for reasonableness. We base our estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that may not be readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We describe our significant accounting policies in Note 2, “Summary of Significant Accounting Policies,” of our Notes to Consolidated Financial Statements included in our Annual Report. We discuss our critical accounting policies and estimates in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of our Annual Report. There have been no material changes in our significant accounting policies or critical accounting policies and estimates since the end of fiscal year 2014.

Company Overview

Quality Systems, Inc. was incorporated in California in 1974. Our principal offices are located at 18111 Von Karman Ave., Suite 700, Irvine, California, 92612. We operate on a fiscal year ending on March 31.

Our Company was founded with an early focus on providing information systems to dental group practices. This focus area would later become the QSI Dental Division. In the mid-1980s, we capitalized on the increasing focus on medical cost containment and further expanded our information processing systems to serve the ambulatory market. In the mid-1990s, we made two acquisitions that accelerated our penetration of the ambulatory market and formed the basis for the NextGen Division. In the last few years, we acquired several companies as part of our strategy to enhance our EDI and RCM services capabilities as well as expand into the small and specialty hospital market. More recently, we acquired Mirth Corporation ("Mirth"), which operates under the NextGen Division, and is expected to enhance our current enterprise interoperability initiatives and broaden our accountable and collaborative care, population health, disease management and clinical data exchange offerings. Today, we serve the dental, ambulatory, hospital and RCM services markets through our QSI Dental Division, NextGen Division, Hospital Solutions Division and RCM Services Division.

The Divisions have historically operated as stand-alone operations, with each Division maintaining its own distinct product lines, product platforms, development, implementation and support teams and branding. However, there are a growing number of customers who are simultaneously utilizing software or services from more than one of our Divisions. In an effort to encourage this cross selling of our products and services between Divisions, we are in the process of further integrating our ambulatory and hospital products to provide a more robust and comprehensive platform to offer our customers. The Divisions also share the resources of our “corporate office,” which includes a variety of accounting and other administrative functions.

In September 2012, we announced certain organizational changes to achieve greater efficiency and integration in our operations as well as to enhance our ability to cross sell products and services to our customers. The changes consolidated Sales, Marketing, Information Technology, and Software Development responsibilities into separate Company-wide roles. We also announced the hiring of a Chief Operating Officer, reporting directly to the Chief Executive Officer, responsible for the operations of the Company across all Divisions. We are continuing to evaluate the organizational structure of the Company with the objective to achieve greater synergies and further integration of our products and services, including software implementation and customer support functions.

The QSI Dental Division, NextGen Division and Hospital Solutions Division develop and market software that is designed to automate and streamline a number of the administrative functions required for operating a medical, dental, or hospital practice, such as patient scheduling and billing. It is important to note that since in both the medical and dental environments, practice management software systems have already been implemented by the vast majority of practices, we actively compete in a replacement market by leveraging the benefits of our interoperable electronic health records software. With the addition of Mirth, our combined solutions enrich the already strong collaborative, connected care support and set the stage for data synchronization, interoperability growth and expansion of our current accountable and collaborative care, population health, disease management and clinical data exchange offering. These Divisions also develop and market software that automates patient records in physician practices, community health centers and hospital settings. In this patient records area of our business, we are typically competing to replace paper-based patient record alternatives as opposed to replacing previously purchased systems. The Hospital Solutions Division develops and markets financial management and billing software products, which perform administrative functions required for operating small and specialty hospitals as well as clinical offerings such as multi-disciplinary clinical documentation and computerized physician order entry. The RCM Services Division provides technology solutions and outsourcing services to cover the full spectrum of healthcare providers' RCM needs, with a primary focus on outsourced billing and collection services.

In January 2011, QSIH was formed in Bangalore, India to function as our India-based captive to offshore technology application development and business processing services. Our employee base in Bangalore has since grown to over 250 employees with a primary focus on software development activities.

We continue to pursue product and service enhancement initiatives within each of our Divisions. The majority of such expenditures are currently targeted to the product lines and client base of the NextGen Division.

The following table reflects our reported segment revenue and segment revenue growth by Division for the three months ended June 30, 2014 and 2013:



	Segment Revenue Breakdown
	Three Months Ended June 30,
	2014		2013
QSI Dental Division	3.6	%	4.7	%
NextGen Division	77.8	%	74.4	%
Hospital Solutions Division	3.5	%	5.0	%
RCM Services Division	15.1	%	15.9	%
Consolidated	100.0	%	100.0	%



	Segment Revenue Growth (Decline)
	Three Months Ended June 30,
	2014		2013
QSI Dental Division	(17.6	)%	4.0	%
NextGen Division	12.5	%	(5.4	)%
Hospital Solutions Division	(23.6	)%	(51.9	)%
RCM Services Division	2.2	%	10.1	%
Consolidated	7.6	%	(7.4	)%

QSI Dental Division. The QSI Dental Division, co-located with our corporate headquarters in Irvine, California, focuses on developing, marketing and supporting software suites sold to dental group organizations located throughout the United States. The QSI Dental Division sells additional licenses to its legacy products as existing clients expand their operations, and sells its cloud-based Software as a Service ("SaaS") model practice management and clinical software solutions to new and existing customers. This software solution, QSIDental Web ("QDW"), is marketed primarily to multi-location dental group practices in which the QSI Dental Division has historically been a dominant player. QDW offers a lower cost of ownership as it is a cloud-based solution that requires a customer to have Internet access to run the application. Further, QSI Dental sells its Electronic Dental Chart in conjunction with NextGen PM and EHR ("Electronic Health Record") and is marketed as NextGen® EDR (“Electronic Dental Record”) to Federally Qualified Health Centers (“FQHC”) and other safety net entities further defined below.

The QSI Dental Division participates jointly with the NextGen Division in providing software and services to safety-net clinics like FQHCs and other “safety net” health centers, including Public Health Centers, Community Health Centers, Free Clinics, as well as Rural and Tribal Health Centers. FQHCs are community-based organizations and are funded by the federal government, which provide medical and dental services to underprivileged and underserved communities. The Patient Protection and Affordable Care Act, which was signed into law in March 2010, reserved $11 billion over a multi-year period for FQHCs, creating unprecedented opportunities for FQHCs growth and the formation of new FQHCs. When combined and used in tandem, NextGen® EHR, NextGen® EDR, and NextGen® PM provide a unique product in this marketplace — an integrated patient record accessible by both physicians and dentists. On May 3, 2013, NextGen® EDR version 4.3 was ONC-ATCB certified by the Certification Commission for Health Information ("CCHIT®") as a complete EHR and complies with all clinical quality measures for Eligible Providers. The additional software NextGen® EDR version 4.3 relied on to demonstrate compliance was NextGen® EHR version 5.8.

The QSI Dental Division's legacy practice management software suite uses a UNIX® operating system. It's Clinical Product Suite (“CPS”) can be fully integrated with the client server-based practice management software offered from each of our Divisions. When integrated and delivered with the NextGen® PM solution, CPS is re-branded as NextGen® EDR. CPS/EDR incorporates a wide range of clinical tools including, but not limited to, periodontal charting and digital imaging of X-ray and inter-oral camera images as part of the electronic patient record. The QSI Dental Division also develops, markets, and provides EDI services to dental practices, including electronic submission of claims to insurance providers as well as automated patient statements.

On November 14, 2011 we acquired ViaTrack, a developer and provider of information technologies that enhance EDI offerings. This acquisition provides a platform to pursue significant opportunities that exist to leverage ViaTrack's technologies to reduce costs and enhance our EDI offerings to all divisions.

NextGen Division. The NextGen Division, with headquarters in Horsham, Pennsylvania and a significant location in Atlanta, Georgia, provides integrated clinical, financial and connectivity solutions for ambulatory and dental provider organizations. The NextGen Division's major product categories include the NextGen® Ambulatory product suite and NextGen® Community Connectivity.

The NextGen Ambulatory product suite streamlines patient care with standardized, real-time clinical and administrative workflows within a physician’s practice, and major product categories include NextGen® EHR, NextGen® PM, NextGen® Dashboard, NextGen® Mobile, and NextGen® NextPen. NextGen® Community Connectivity consists of NextGen® Health Information Exchange (formerly Community Health Solution), NextGen® Patient Portal (NextMD.com), and NextGen® Health Quality Measures. The NextGen Division also offers hosting services, NextGuard – Data Protection services, and consulting services, such as strategic governance models and operational transformation,

technical consulting such as data conversions or interface development. The NextGen Division products utilize Microsoft Windows technology and can operate in a client-server environment as well as via private intranet, the Internet, or in an ASP environment. The NextGen Division also provides EDI services, which include electronic submission of claims to insurance providers as well as automated patient statements.

On September 9, 2013, we acquired Mirth, a global leader in health information technology that helps clients achieve interoperability. Operating results associated with Mirth products and services are included in the NextGen Division. The acquisition of Mirth will enhance our current enterprise interoperability initiatives and broaden our accountable and collaborative care, population health, disease management and clinical data exchange offerings. Mirth offers a wide variety of products and services utilized by both users of Mirth open code technology as well as a large base of domestic and international paying customers. Product offerings available from Mirth include Mirth Connect, Mirth Results, Mirth Match, Mirth Mail, Mirth Appliance, Mirth Care and Mirth Gateway. As a direct result of the Mirth acquisition, we introduced NextGen® Share to our customer base in November 2013. As our first offering that integrates technologies from both NextGen Healthcare and Mirth, NextGen® Share provides the ability to securely and easily share patient charts and other data with other practices using NextGen Internet based software.

Hospital Solutions Division. The Hospital Solutions Division, with its primary location in Austin, Texas, provides integrated clinical, financial and connectivity solutions for rural, community and specialty hospitals. This Hospital Solutions Division also develops and markets an equivalent revenue cycle management and clinical information systems software products for the small and specialty hospital market, which perform the administrative functions required for operating hospitals.

In the last few years, we have acquired companies that were established developers of software and services for the hospital market to operate under the Hospital Solutions Division. On May 1, 2012, we acquired The Poseidon Group, a provider of emergency department software. On July 26, 2011, we acquired CQI Solutions, Inc., a provider of hospital systems for surgery management. On April 29, 2011, we acquired IntraNexus, Inc., a provider of Web-based integrated clinical and hospital information systems. On February 10, 2010, we acquired Opus Healthcare Solutions, LLC, a provider of Web-based clinical solutions to hospital systems and integrated health networks nationwide and on August 12, 2009 we acquired Sphere Health Systems, Inc., a provider of financial information systems to the small hospital inpatient market. These acquisitions are part of our long term strategy to expand in the small and specialty hospital market and to add new clients by taking advantage of cross selling opportunities between the ambulatory and hospital markets.

RCM Services Division. The RCM Services Division, with locations in St. Louis, Missouri, North Canton, Ohio, South Jordan, Utah and Hunt Valley, Maryland, provides technology solutions and consulting services to cover the full spectrum of healthcare providers' RCM needs, from patient access through claims denials, with a primary focus on billing and collection services. The RCM Services Division combines a Web-delivered SaaS model and the NextGen® PM software platform to execute its service offerings. Execution of the plan to transition our client base onto the NextGen platform is being implemented. On April 15, 2012, we acquired Matrix Management Solutions, LLC (“Matrix”). Since 1998, North Canton, Ohio-based Matrix, a value-added reseller for NextGen Healthcare, has provided RCM services, healthcare information technology solutions and training, implementation and support centered on NextGen technology, to its clients nationwide. The acquisition has enabled our RCM Services Division to expand its footprint among private and hospital-based physicians and groups by leveraging Matrix's RCM expertise.

Overview of Our Results

•

Consolidated revenue increased 7.6% in the three months ended June 30, 2014 as compared to the prior year period. The increase reflects a 11.4% increase in recurring services revenue (i.e. maintenance, EDI, RCM and other services revenues), mitigated by a 6.8% decrease in system sales revenue. The decline in system sales revenue reflects the increasingly saturated markets in which our core software products are sold.

•

Consolidated gross profit as a percentage of revenue decreased to 52.3% for the three months ended June 30, 2014 compared to 56.1% in the prior year period. The decline is primarily the result of a shift in the mix of revenue towards lower-margin recurring services. For the three months ended June 30, 2014, recurring services revenue comprised 82.2% of consolidated revenue, as compared to 79.4% in the prior year period.


•	Consolidated operating income decreased 60.3% , or $11.8 million, in the three months ended June 30, 2014 as compared to the prior year period primarily due to a $10.6 million increase in research and development costs as compared to the prior year period resulting from lower capitalization rates of software development costs.

QSI Dental Division

QSI Dental Division revenue decreased 17.6% in the three months ended June 30, 2014. Divisional operating income (excluding Corporate and unallocated amounts) was $0.9 million in the three months ended June 30, 2014, a decrease of 43.0% as compared to the same prior year period. The decrease in operating income was primarily the result of a $0.6 million decrease in system sales revenue. It should be noted that the division's new software solution, QDW, is being sold as a SaaS solution for which revenue is recognized over a longer period of time rather than upfront. Revenue recognized from QDW was not significant in the three months ended June 30, 2014.


•	The QSI Dental Division is well-positioned to sell to the FQHCs market and intends to continue leveraging the NextGen Division's sales force to sell its dental electronic medical records software to practices that provide both medical and dental services, such as FQHCs, which are receiving grants as part of the ARRA.


•	Our goal for the QSI Dental Division is to maximize profit performance given the constraints represented by a relatively weak purchasing environment in the dental group practice market while taking advantage of opportunities with the new QDW product.

NextGen Division

•

NextGen Division revenue increased 12.5% in the three months ended June 30, 2014, as compared to the same prior year period. This variance reflects a 16.4% growth in recurring service revenue, including an increase of 8.6% in maintenance, 10.3% in EDI revenue and 42.9% in other services revenue. The acquisition of Mirth in September 2013 contributed to the growth in other services revenue for the three months ended June 30, 2014. Recurring service revenue increased to $72.5 million and accounted for 79.1% of total NextGen Division revenue for the three months ended June 30, 2014. In the same period a year ago, recurring service revenue of $62.3 million represented 76.5% of total NextGen Division revenue.


•	NextGen Division operating income (excluding Corporate and unallocated amounts) increased by 20.0% in the three months ended June 30, 2014, as compared to the same prior year period. The increase in operating income is primarily the result of the increase in total revenue and a decline in operating expenses.

•

Our goals include taking maximum advantage of benefits related to the ARRA and continuing to further enhance our existing products, including continued efforts to maintain our status as a qualified vendor under the ARRA, expanding our software and service offerings supporting pay-for-performance initiatives around accountable care organizations, bringing greater ease of use and intuitiveness to our software products, expanding our interoperability capabilities, integrating our hospital and ambulatory software products and further development and enhancements of our portfolio of specialty focused templates within our EHR software. We intend to remain at the forefront of upcoming new regulatory requirements, including ICD-10 and meaningful use requirements for stimulus payments. We believe that the expanded requirements for continued eligibility for incentive payments under meaningful use rules will result in an expanded replacement market for electronic health records software. We also intend to continue selling additional software and services to existing clients, expanding penetration of connectivity and other services to new and existing clients, and capitalizing on growth and cross selling opportunities within the RCM Services Division. We believe that our acquisition of Mirth will provide improved capabilities around interoperability and improved competitiveness in our markets, as well as providing new customers and expanded markets for the NextGen Division.

•

The latest significant versions of our ambulatory software products achieved general release during the third quarter of fiscal 2014. Due to the overall increase in the capitalized software costs balance, we expect that these releases will result in significantly higher rates of amortization relative to previously capitalized software development costs reflected in our recent historical operating results. Amortization of capitalized software costs are reflected as cost of revenue on our Consolidated Statements of Comprehensive Income. Refer to Note 5, “Capitalized Software Costs” of our notes to the consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for an estimate of future amortization of capitalized software costs as of June 30, 2014. We have also noted a trend towards shorter development cycles, which impacts our rate of capitalization of software development costs. Although lower capitalization rates have no impact on our overall cash flows, it results in a higher portion of our software development costs being expensed up front, resulting in increased research and development expenses as compared to prior periods.

•

The NextGen Division’s growth is attributed to a strong brand name and reputation within the marketplace for healthcare information technology software and services and investments in sales and marketing activities, including new marketing campaigns, Internet advertising investments, trade show attendance and other expanded advertising and marketing expenditures. We have also recently expanded our relationship with certain value added resellers with significant resources both domestically and internationally.

Hospital Solutions Division


•	Hospital Solutions Division revenue decreased 23.6% in the three months ended June 30, 2014. Revenue was negatively impacted by a 43.6% decline in system sales, as well as lower maintenance revenue and higher accruals for anticipated sales credits.


•	Divisional operating loss (excluding Corporate and unallocated amounts) was $1.1 million for the three months ended June 30, 2014 as compared to a $0.7 million loss for the same prior year period. The decline in operating results is primarily due to the decline of divisional revenue.

•

The Hospital Solutions Division has incurred losses in the last several quarters and is expected to continue to incur losses for the foreseeable future while we continue to invest in implementation and training, support, and development to support our customer base and maximize customer satisfaction. Our expectations about the future performance of this Division resulted in the full impairment of significant long-term assets of this Division during the three months ended December 31, 2013. Along with recording the impairment charge, we have also ceased capitalization and amortization of software development costs at this Division. For the three months ended June 30, 2013, total capitalized software costs were approximately $0.9 million and total amortization of previously capitalized amounts was approximately $0.4 million.

RCM Services Division


•	RCM Services Division revenue increased 2.2% in the three months ended June 30, 2014. The RCM Services Division benefited from organic growth achieved through cross selling RCM services to existing NextGen Division clients, as well as new clients added during the three months ended June 30, 2014.


•	Operating income decreased 39.2% in the three months ended June 30, 2014 as compared to the same prior year period primarily as a result of a decrease in divisional gross profit compared to the prior year period.

•

The Company believes that a significant opportunity exists to continue cross selling RCM services to existing customers. The portion of existing NextGen customers who are using the RCM Services Division's services is less than 10%. Management is actively pursuing efforts to achieve faster growth from expanded efforts to leverage the existing NextGen Division's sales force towards selling RCM services. We also believe that the increased complexity related to the billing and collections process, expected to go into effect with ICD-10, will create additional opportunities for our RCM Services Division.


•	Actual and expected customer turnover may impact short term revenue for the division. However, we are encouraged by increased sales activity and a growing sales pipeline of RCM services.

Corporate and unallocated amounts (costs not allocated to the operating segments)

•

Effective April 1, 2014, we refined the measurement of our segment data to better reflect an organizational structure whereby certain expenses managed by functional area leadership are no longer classified within the operating segments but rather as a component of Corporate and unallocated. Such classification is consistent with the disaggregated financial information used by the chief decision making group. As a result, we no longer classify the amortization of capitalized software costs within the operating segments. The Company has retroactively reclassified the prior year gross margin amounts included in the MD&A to present all segment information on a comparable basis. For additional details, refer to Note 12, “Operating Segment Information,” of our notes to consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

The following table sets forth, for the periods indicated, the percentage of net revenue represented by each item in our consolidated statements of income (certain percentages below may not sum due to rounding):



	Three Months Ended June 30,
(Unaudited)	2014		2013
Revenues:
Software and hardware	12.5	%	14.6	%
Implementation and training services	5.3		6.0
System sales	17.8		20.6
Maintenance	34.6		35.2
Electronic data interchange services	15.5		15.2
Revenue cycle management and related services	14.2		14.6
Other services	17.9		14.3
Maintenance, EDI, RCM and other services	82.2		79.4
Total revenues	100.0		100.0
Cost of revenue:
Software and hardware	5.6		4.5
Implementation and training services	6.1		6.5
Total cost of system sales	11.7		11.0
Maintenance	5.9		4.8
Electronic data interchange services	10.2		9.9
Revenue cycle management and related services	10.8		10.4
Other services	9.1		7.8
Total cost of maintenance, EDI, RCM and other services	36.0		32.9
Total cost of revenue	47.7		43.9
Gross profit	52.3		56.1
Operating expenses:
Selling, general and administrative	31.2		32.0
Research and development costs	13.8		5.1
Amortization of acquired intangible assets	0.8		1.1
Total operating expenses	45.8		38.2
Income from operations	6.6		17.9
Other income (expense), net	0.0		(0.2)
Income before income taxes	6.6		17.6
Provision for income taxes	2.3		5.8
Net income	4.3	%	11.8	%

Comparison of the Three Months Ended June 30, 2014 and June 30, 2013

Net Income. Our net income for the three months ended June 30, 2014 was $5.2 million, or $0.09 per share on a basic basis and $0.08 per share on a fully diluted basis. In comparison, we earned net income of $12.9 million, or $0.22 per share, on both a basic and fully diluted basis for the three months ended June 30, 2013. The change in net income for the three months ended June 30, 2014 was primarily attributed to the following:

•

a 6.8% decline in consolidated system sales revenue related to a number of factors, including higher adoption rates by large physician groups resulting in a lower number of new opportunities, the consolidation of physician offices by hospitals and other large enterprises thereby reducing the number of potential opportunities, and an extension of the deadline to adopt stage two meaningful use requirements until calendar 2014.


•	a $12.0 million, or 28.7%, increase in total operating expenses compared to the prior year period. This increase is primarily due to a 189.2% increase in research and development expenses in the current period primarily due to the lower capitalization rates of software development costs relating to a trend towards shorter development cycles, which impacts our rate of capitalization.


•	a reduction of $3.7 million in the provision for income taxes, primarily a result of the decline of net income.

Revenue. Revenue for the three months ended June 30, 2014 increased 7.6% to $117.9 million from $109.5 million for the three months ended June 30, 2013. NextGen Division revenue increased 12.5% to $91.7 million compared to $81.5 million in the three months ended June 30, 2013, RCM Services Division revenue increased 2.2% to $17.8 million from $17.4 million, and the Hospital Solutions Division revenue decreased 23.6% during that same period to $4.2 million from $5.5 million. Revenue for the QSI Dental Division decreased 17.6% to $4.2 million from $5.2 million compared to the same prior year period.

System Sales. Revenue earned from our company-wide sales of systems for the three months ended June 30, 2014 decreased 6.8% to $21.0 million from $22.5 million in the same prior year period.

The following table breaks down our reported system sales into software, hardware and third-party software, and implementation and training services components on a consolidated and divisional basis for the three months ended June 30, 2014 and 2013 (in thousands):



	Software			Hardware and Third Party Software			Implementation and Training Services		Total System Sales
Three Months Ended June 30, 2014
QSI Dental Division	$	159		$	247		$	186	$	592
NextGen Division	12,702			967			5,497		19,166
Hospital Solutions Division	1,137			(567		)	583		1,153
RCM Services Division	98			—			—		98
Consolidated	$	14,096		$	647		$	6,266	$	21,009
Three Months Ended June 30, 2013
QSI Dental Division	$	551		$	391		$	277	$	1,219
NextGen Division	13,496			1,398			4,297		19,191
Hospital Solutions Division	(40		)	83			2,001		2,044
RCM Services Division	93			—			—		93
Consolidated	$	14,100		$	1,872		$	6,575	$	22,547

The decrease in system sales was driven primarily by lower sales of software, hardware, and third party software to both new and existing clients for the NextGen Division. NextGen Division software license revenue decreased 5.9% in the three months ended June 30, 2014 versus the same period last year. The NextGen Division’s software revenue accounted for 66.3% of divisional system sales revenue during the three months ended June 30, 2014 compared to 70.3% during the same period a year ago. Software license revenue continues to be an area of primary emphasis for the NextGen Division.

We believe there are other trends which may positively impact future systems sales. Many of our existing large enterprise customers have plans to grow, which will create future revenue opportunities as these customers purchase additional software and services to support their growth plans. We also expect to benefit from the growth of a replacement market driven by an expected consolidation of electronic health records vendors. Finally, we believe many new opportunities will be created by the evolution of healthcare from a pay for services reimbursement model to a pay for performance model around the management of patient populations. Additionally, the Mirth acquisition provided us with new products and services around HIE and interoperability, which we intend to utilize to drive future growth. It is difficult to assess the relative impact as well as the timing of positive and negative trends, however, we believe we are well positioned to support the ever increasing need for healthcare information technology.

During the three months ended June 30, 2014, 5.0% of the NextGen Division’s system sales revenue was represented by hardware and third party software compared to 7.3% during same period a year ago. The number of clients who purchase hardware and third party software and the dollar amount of hardware and third party software revenue fluctuates each quarter depending on the needs of clients. The inclusion of hardware and third party software in the NextGen Division’s sales arrangements is typically at the request of our clients.

Implementation and training revenue related to system sales at the NextGen Division increased 27.9% in the three months ended June 30, 2014 compared to the same prior year period. Implementation and training revenue related to system sales at the Hospital Solutions Division decreased 70.9%, in the three months ended June 30, 2014 as compared to the same prior year period. The amount of implementation and training services revenue is dependent on several factors, including timing of client implementations, the availability of qualified staff and the mix of services being rendered. It should be noted that we have experienced a decline in the level of systems sales in recent quarters which in turn have resulted in a decline in the amount of implementation services sold. We have not had significant reductions in our staffing levels despite the decline in revenue as we believe that the demand for services is going to increase especially as our customers implement the newest release of our core ambulatory software products, which support new ICD-10 billing requirements.

Maintenance, EDI, RCM and Other Services. For the three months ended June 30, 2014, our consolidated revenue from maintenance, EDI, RCM and other services grew 11.4% to $96.9 million from $87.0 million in the same prior year period. The increase is due to an increase across all categories of recurring service revenue.

The following table details maintenance, EDI, RCM and other services revenue by category on a consolidated and divisional basis for the three months ended June 30, 2014 and 2013 (in thousands):



	Maintenance		EDI		RCM		Other		Total
Three Months Ended June 30, 2014
QSI Dental Division	$	1,881	$	1,290	$	—	$	480	$	3,651
NextGen Division	36,603		16,800		—		19,145		72,548
Hospital Solutions Division	2,182		40		—		801		3,023
RCM Services Division	139		189		16,693		642		17,663
Consolidated	$	40,805	$	18,319	$	16,693	$	21,068	$	96,885
Three Months Ended June 30, 2013
QSI Dental Division	$	2,111	$	1,406	$	—	$	415	$	3,932
NextGen Division	33,707		15,236		—		13,401		62,344
Hospital Solutions Division	2,582		37		—		804		3,423
RCM Services Division	208		13		16,015		1,047		17,283
Consolidated	$	38,608	$	16,692	$	16,015	$	15,667	$	86,982

Total NextGen Division maintenance revenue for the three months ended June 30, 2014 grew 8.6% to $36.6 million from $33.7 million for the same prior year period while NextGen Division EDI revenue grew 10.3% to $16.8 million compared to $15.2 million in the same prior year period. Maintenance revenue for the NextGen Division increased by $2.9 million for the three months ended June 30, 2014 as compared to the same prior year period, primarily as a result of net additional licenses from both new and existing clients and the addition of Mirth maintenance revenue. The NextGen Division’s EDI revenue growth has come from new clients and from further penetration of the division’s existing client base. Other services revenue for the NextGen Division, which consists primarily of third party annual software license renewals, consulting services, SaaS fees, hosting services, and other subscriptions increased 42.9% to $19.1 million in the three months ended June 30, 2014 from $13.4 million in the same prior year period. Other services revenue benefited from a strong increase in consulting revenue to existing NextGen Division customers as well as the addition of Mirth subscription revenue.

QSI Dental Division maintenance, EDI and other services revenue for the three months ended June 30, 2014 and 2013 was $3.7 million and $3.9 million, respectively. For the three months ended June 30, 2014, RCM revenue for the RCM Services Division increased to $16.7 million compared to $16.0 million in the same prior year period. The growth in RCM revenue is primarily attributable to organic growth achieved through cross selling RCM services to existing NextGen Division clients, as well as new clients. For the Hospital Solutions Division, maintenance and other services revenue for the three months ended June 30, 2014 decreased 11.7% as compared to the same prior year period primarily due to a decrease in maintenance revenue primarily due to decreases in the amount of maintenance services provided to existing customers.

We intend to continue to promote maintenance, EDI and RCM services to both new and existing clients.

Cost of Revenue. Cost of revenue for the three months ended June 30, 2014 increased to $56.2 million from $48.1 million in the same prior year period and the cost of revenue as a percentage of revenue increased to 47.7% from 43.9%. The increase in the cost of revenue as a percentage of revenue is primarily due to a change in the mix of revenues toward recurring services revenue, which have historically experienced a lower profit margin than system sales.

The following table details revenue and cost of revenue on a consolidated and divisional basis for the three months ended June 30, 2014 and 2013 (in thousands):



	Three Months Ended June 30,
	2014			%		2013		%
QSI Dental Division
Revenue	$	4,243		100.0	%	$	5,151	100.0	%
Cost of revenue	2,317			54.6	%	2,392		46.4	%
Gross profit	$	1,926		45.4	%	$	2,759	53.6	%
NextGen Division
Revenue	$	91,714		100.0	%	$	81,535	100.0	%
Cost of revenue	31,881			34.8	%	26,856		32.9	%
Gross profit	$	59,833		65.2	%	$	54,679	67.1	%
Hospital Solutions Division
Revenue	$	4,176		100.0	%	$	5,467	100.0	%
Cost of revenue	4,306			103.1	%	3,875		70.9	%
Gross profit (loss)	$	(130	)	(3.1	)%	$	1,592	29.1	%
RCM Services Division
Revenue	$	17,761		100.0	%	$	17,376	100.0	%
Cost of revenue	13,195			74.3	%	11,883		68.4	%
Gross profit	$	4,566		25.7	%	$	5,493	31.6	%
Unallocated cost of revenue	$	4,491		N/A		$	3,066	N/A
Consolidated
Revenue	$	117,894		100.0	%	$	109,529	100.0	%
Cost of revenue	56,190			47.7	%	48,072		43.9	%
Gross profit	$	61,704		52.3	%	$	61,457	56.1	%

Gross profit margins for the NextGen Division, QSI Dental Division and the Hospital Solutions Division decreased for the three months ended June 30, 2014 compared to the same prior year period primarily due to a decrease in total system sales (consisting of software and hardware sales and training and implementation services). Gross profit margin for the RCM Services Division declined compared to the same prior year period primarily due to an increase in cost of revenue at a higher rate than the increase in related revenue.

The following table details the individual components of cost of revenue and gross profit (loss) as a percentage of total revenue on a consolidated and divisional basis for the three months ended June 30, 2014 and 2013:



	Software		Hardware and Third Party Software		Payroll and Related Benefits		EDI		Other		Total Cost of Revenue		Gross Profit (Loss)
Three Months Ended June 30, 2014
QSI Dental Division	0.0	%	4.0	%	34.1	%	9.0	%	7.5	%	54.6	%	45.4	%
NextGen Division	1.4	%	0.8	%	11.9	%	11.5	%	10.6	%	34.8	%	65.2	%
Hospital Solutions Division	0.0	%	0.5	%	81.0	%	0.5	%	21.1	%	103.1	%	(3.1	)%
RCM Services Division	0.0	%	0.0	%	49.6	%	1.0	%	23.7	%	74.3	%	25.7	%
Consolidated	4.9	%	0.8	%	20.9	%	9.5	%	16.5	%	47.7	%	52.3	%
Three Months Ended June 30, 2013
QSI Dental Division	2.6	%	6.1	%	19.7	%	14.3	%	6.3	%	46.4	%	53.6	%
NextGen Division	(0.1	)%	1.5	%	12.4	%	11.4	%	7.6	%	32.9	%	67.1	%
Hospital Solutions Division	3.5	%	0.7	%	40.9	%	0.4	%	28.9	%	70.9	%	29.1	%
RCM Services Division	0.0	%	0.0	%	42.9	%	0.9	%	24.6	%	68.4	%	31.6	%
Consolidated	3.0	%	1.5	%	19.0	%	9.3	%	14.1	%	43.9	%	56.1	%

During the three months ended June 30, 2014, hardware and third-party software constituted a slightly lower portion of cost of revenue compared to the same prior year period in the NextGen Division. The number of clients who purchase hardware and third-party software and the dollar amount of hardware and third-party software purchased fluctuates each quarter depending on the needs of our clients.

Gross margin for the Hospital Solutions Division decreased to (3.1)% for the three months ended June 30, 2014 as compared to 29.1% for the same prior year period primarily due to the declines in system sales revenues, implementation and training gross margin, and maintenance gross margin. The change in maintenance gross margin was primarily a result of increased accruals for anticipated sales credits, which

reduced revenue in the current period. The gross margin for implementation and training was negatively impacted by a decline in implementation revenue without requisite reductions in our implementation staffing levels at the Hospital Solutions Division.

Our payroll and benefits expense associated with delivering our products and services increased to 20.9% of consolidated revenue in the three months ended June 30, 2014 compared to 19.0% during the same period last year. The absolute level of consolidated payroll and benefit expenses increased from $20.8 million in the three months ended June 30, 2013 to $24.6 million in the three months ended June 30, 2014. The increase is primarily due to a $1.1 million increase in payroll and benefits expenses within the Hospital Solutions Division, resulting from increased headcount compared to the prior year period and a $1.4 million increase within the RCM Services Division, as RCM is a service business which inherently has higher payroll costs as a percentage of revenue. The amount of share-based compensation expense included in cost of revenue was not significant for the three months ended June 30, 2014 and 2013.

Other cost of revenue, which primarily consists of third-party annual licenses, hosting costs and outsourcing costs, increased to 16.5% of total revenue during the three months ended June 30, 2014 as compared to 14.1% for the same period a year ago. Other expenses as a percentage of revenue increased due to the mix of other services revenue sold compared to the prior year period.

As a result of the foregoing events and activities, our gross profit percentage decreased to 52.3% for the three months ended June 30, 2014 versus 56.1% for the same prior year period.

Selling, General and Administrative Expenses. Selling, general and administrative expenses for the three months ended June 30, 2014 increased 4.7% to $36.7 million as compared to $35.1 million for the prior year period. The increase in these expenses is primarily due to the inclusion of Mirth, which was acquired on September 9, 2013. The increase in selling, general and administrative expenses, including the impact of Mirth, consists primarily of:


•	$2.1 million increase in compensation costs, including salaries, benefits, and commissions


•	$1.1 million increase in acquisition costs; and


•	$1.3 million net increase in other selling and administrative expenses; partially offset by


•	$2.9 million decrease in bad debt expense as a result of improved collections.

Share-based compensation expense was approximately $0.6 million and $0.4 million for the three months ended June 30, 2014 and 2013, respectively, and is included in the aforementioned amounts. Selling, general and administrative expenses as a percentage of revenue decreased from 32.0% in the three months ended June 30, 2013 to 31.2% in the three months ended June 30, 2014.

Research and Development Costs. Research and development costs for the three months ended June 30, 2014 and 2013 were $16.2 million and $5.6 million, respectively. Research and development costs as a percentage of revenue increased to 13.8% in the three months ended June 30, 2014 from 5.1% for the prior year period. The increase in research and development expenses is primarily due to the reduction in the capitalization rate of software development costs in the current period resulting from a trend towards shorter development cycles, the acquisition of Mirth, as well as the continued investment in enhancements to our specialty template development, preparation for ICD-10 requirements, new products including NextGen Knowledge Base Model, NextGen Mobile, NextGen NextPen, NextGen Community Connectivity consisting of NextGen HIE, NextGen Patient Portal (NextMD.com), and NextGen Health Quality Measures, and other enhancements to our existing products.

Additions to capitalized software costs offset increases in research and development costs. For the three months ended June 30, 2014 and 2013, our additions to capitalized software were $2.9 million and $7.3 million, respectively. The decrease in capitalized software is primarily due to the cessation of software development costs capitalization at the Hospital Solutions Division as a result of the prior year impairment charge. For the three months ended June 30, 2014 and 2013, total research and development expenditures including costs expensed and costs capitalized was $19.1 million and $12.9 million, respectively. We intend to continue to invest heavily in research and development to enhance our software to meet the Meaningful Use definitions under the ARRA as well as further integrate both ambulatory and inpatient products and to develop a new integrated inpatient and outpatient, web-based software platform as well as continue to bring additional functionality and features to the medical community. Share-based compensation expense included in research and development costs was not significant for the three months ended June 30, 2014 and 2013.

Amortization of Acquired Intangible Assets. Amortization included in operating expenses related to acquired intangible assets decreased to $1.0 million for the three months ended June 30, 2014 from $1.2 million from the prior year period.

Provision for Income Taxes. The provision for income taxes for the three months ended June 30, 2014 and 2013 was $2.7 million and $6.4 million, respectively. The effective tax rates were 34.0% and 33.0% for the three months ended June 30, 2014 and 2013, respectively. The effective rate for the three months ended June 30, 2014 increased as compared to the same prior year period primarily due to the absence of a federal research and development tax credit reflected in the current period, offset by the increased benefit of the foreign rate differential and decrease in qualified production activities deduction. The federal research and development tax credit statute expired on December 31, 2013 and has not been reenacted as of June 30, 2014.

Liquidity and Capital Resources

The following table presents selected financial statistics and information for the three months ended June 30, 2014 and 2013 (in thousands):



	Three Months Ended June 30,
	2014		2013
Cash and cash equivalents and marketable securities	$	116,435	$	130,026
Net decrease in cash and cash equivalents and marketable securities	$	2,634	$	12,015
Net income	$	5,163	$	12,945
Net cash provided by operating activities	$	18,565	$	31,527
Number of days of sales outstanding (1)	87		116

_________________________

(1) Days sales outstanding is equal to accounts receivable divided by average daily revenue.

Cash Flows from Operating Activities

Cash provided by operations has historically been our primary source of cash and has primarily been driven by our net income, as adjusted to exclude non-cash expenses, such as depreciation, amortization of intangibles and capitalized software costs, provision for bad debts and inventory obsolescence, share-based compensation, changes in fair value of contingent consideration and deferred taxes.

The following table summarizes our consolidated statements of cash flows for the three months ended June 30, 2014 and 2013 (in thousands):



	Three Months Ended June 30,
	2014		2013
Net income	$	5,163	$	12,945
Non-cash expenses	7,874		9,301
Cash from net income (as adjusted)	13,037		22,246
Change in accounts receivable	3,172		7,503
Change in other assets and liabilities	2,356		1,778
Net cash provided by operating activities	$	18,565	$	31,527

Net cash provided by operating activities for the three months ended June 30, 2014 and 2013 was approximately $18.6 million and $31.5 million, respectively. Cash from operations for the three months ended June 30, 2014 decreased as a result of the decline in cash from net income and a $4.3 million decrease in cash flows attributable to accounts receivable activity, offset slightly by changes in other assets and liabilities. The Company continues to place strong emphasis on working capital management and collections as reflected by a reduction of days sales outstanding (“DSO”) in comparison to the prior year period. Specifically, DSO decreased to 87 days for the three months ended June 30, 2014, as compared to 116 days in the same prior year period. Based on our results for the three months ended June 30, 2014, we anticipate being able to continue generating significant cash from operations for the remainder of fiscal year 2015.

Cash Flows from Investing Activities

Net cash used in investing activities for the three months ended June 30, 2014 and 2013 was approximately $3.2 million and $9.1 million, respectively. The $5.9 million decrease in net cash used in investing activities is primarily due to the decrease of additions to capitalized software costs by $4.4 million, plus $1.9 million in proceeds from the sales and maturities of marketable securities, offset slightly by an increase in additions to equipment and improvements.

Cash Flows from Financing Activities

Net cash used in financing activities for the three months ended June 30, 2014 and 2013 was $10.7 million and $10.2 million, respectively. During the three months ended June 30, 2014, we paid $10.7 million in dividends to shareholders as compared to payments of $10.4 million in dividends to shareholders and proceeds of $0.3 million from the exercise of stock options during the same prior year period.

Cash and Cash Equivalents and Marketable Securities

At June 30, 2014, we had combined cash and cash equivalents and marketable securities of $116.4 million, reflecting an increase of $2.6 million from the comparable balance as of March 31, 2014. This increase principally reflects the continued decrease in DSO and emphasis on working capital management in the current year.

We may use a portion of these funds towards future acquisitions, although the timing and amount of funds to be used has not been determined. We intend to expend some of these funds for the development of products complementary to our existing product line as well as new versions of certain of our products. These developments are intended to take advantage of more powerful technologies and to increase the integration of our products. Such expenditures will be funded from cash on hand and cash flows from operations.

Our investment policy is determined by our Board of Directors. We currently maintain our cash in very liquid short term assets including tax exempt and taxable money market funds, Certificates of Deposit and short term Municipal Bonds with maturities of 365 days or less at the time of purchase. Our Board of Directors continues to review alternate uses for our cash including, but not limited to, payment of a special dividend, initiation of a stock buyback program, an expansion of our investment policy and other items. Additionally, it is possible that we will utilize some or all of our cash to fund acquisitions or other similar business activities. Any or all of these programs could significantly impact our investment income in future periods.

In January 2007, our Board of Directors adopted a practice whereby we intend to pay a regular quarterly dividend on our outstanding common stock, subject to further review and approval, sufficiency of funds and the establishment of record and distribution dates by our Board of Directors prior to the declaration of each such quarterly dividend. We anticipate that future quarterly dividends, if and when declared by our Board of Directors pursuant to this practice, would likely be distributable on or about the fifth day of each January, April, July and October. The Board of Directors has historically shown a strong commitment to the payment of a regular dividend and will continue to evaluate the continued payment of dividends based on our operating cash flows and future capital requirements.

On July 23, 2014, the Board of Directors approved a quarterly cash dividend of $0.175 per share on our outstanding shares of common stock, payable to shareholders of record as of September 12, 2014 with an expected distribution date on or about October 3, 2014.

Our Board of Directors declared the following dividends during the periods presented:




Declaration Date	Record Date	Payment Date	Per Share Dividend
May 28, 2014	June 13, 2014	July 3, 2014	$	0.175
Fiscal year 2015			0.175
May 22, 2013	June 14, 2013	July 5, 2013	0.175
July 24, 2013	September 13, 2013	October 4, 2013	$	0.175
October 23, 2013	December 13, 2013	January 3, 2014	0.175
January 22, 2014	March 14, 2014	April 4, 2014	0.175
Fiscal year 2014			$	0.700
May 24, 2012	June 15, 2012	July 3, 2012	$	0.175
July 25, 2012	September 14, 2012	October 5, 2012	$	0.175
October 25, 2012	December 14, 2012	December 28, 2012	$	0.175
January 23, 2013	March 15, 2013	April 5, 2013	$	0.175
Fiscal year 2013			$	0.700

Management believes that its cash, cash equivalents and marketable securities on hand at June 30, 2014, together with its cash flows from operations, will be sufficient to meet its working capital and capital expenditure requirements, as well as any dividends to be paid in the ordinary course of business, for the next twelve months. Our Board of Directors will continue to evaluate the strategic use of our cash towards payment of dividends in light of both working capital and capital expenditure requirements.

Contractual Obligations

The following table summarizes our significant contractual obligations at June 30, 2014 and the effect that such obligations are expected to have on our liquidity and cash in future periods:



			For the year ended March 31,
Contractual Obligations	Total		2015 (remaining nine months)		2016		2017		2018		2019		2020 and beyond
Operating lease obligations	$	28,730	$	6,161	$	7,812	$	5,880	$	5,146	$	1,971	$	1,760
Contingent consideration and other acquisition related liabilities (excluding share-based payments)	$	625			$	313	$	312	—		—		—
Total	$	29,355	$	6,161	$	8,125	$	6,192	$	5,146	$	1,971	$	1,760

The deferred compensation liability as of June 30, 2014 was $5,182, which is not included in the table above as the timing of future benefit payments to employees is not determinable.

Recent Accounting Pronouncements

Refer to Note 1, “Summary of Significant Accounting Policies,” of our notes to consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for a discussion of new accounting standards.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

There is little to no market risk as we currently maintain our cash in very liquid short term assets including tax exempt and taxable money market funds and short-term U.S. Treasury securities with maturities of 90 days or less at the time of purchase.

Although we have international operations, the impact of foreign currency fluctuations have not been material to our financial position or operating results.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively) have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Security Exchange Act of 1934, as amended, the "Exchange Act") as of June 30, 2014, the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”). They have concluded that, as of the Evaluation Date, these disclosure controls and procedures were effective to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to them by others within those entities and would be disclosed on a timely basis. The Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are designed, and are effective, to give reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the rules and forms of the SEC. They have also concluded that the our disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act are accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

On September 9, 2013, we completed our acquisition of Mirth Corporation. As of June 30, 2014, we have incorporated Mirth Corporation's historical internal controls over financial reporting into the Company’s evaluation of its internal controls and attestation activities pursuant to Section 404 of the Sarbanes-Oxley Act of 2002.

During the quarter ended June 30, 2014, there were no other changes in our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management, including our Chief Executive Officer and Chief Financial Officer, has concluded that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at that reasonable assurance level. However, management can provide no assurance that our disclosure controls and procedures or our internal control over financial reporting can prevent all errors and all fraud under all circumstances. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been or will be detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On November 19, 2013, a putative class action complaint was filed on behalf of the shareholders of the Company other than the defendants against the Company and certain of the Company’s officers and directors in the United States District Court for the Central District of California, captioned Deerfield Beach Police Pension Fund, individually and on behalf of all others similarly situated, v. Quality Systems, Inc., Steven T. Plochocki, Paul A. Holt and Sheldon Razin, No. SACV13-01818-CJC-JPRx, by the Deerfield Beach Police Pension Fund, a shareholder of the Company. After the court appointed lead plaintiffs and lead counsel for this action, lead plaintiffs filed an amended complaint on April 7, 2014. The amended complaint, which is substantially similar to the litigation initiated by Mr. Hussein described above generally alleges that statements made to the Company’s shareholders regarding the Company’s financial condition and projected future performance were false and misleading in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the individual defendants are liable for such statements because they are controlling persons under Section 20(a) of the Exchange Act. The complaint seeks compensatory damages, court costs and attorneys' fees. The Company filed a motion to dismiss the amended complaint on June 20, 2014.

On January 24, 2014, a complaint was filed against the Company and certain of the Company’s officers and current and former directors in the United States District Court for the Central District of California, captioned Timothy J. Foss, derivatively on behalf of himself and all others similarly situated, vs. Craig A. Barbarosh, George H. Bristol, James C. Malone, Peter M. Neupert, Morris Panner, D. Russell Pflueger, Steven T. Plochocki, Sheldon Razin, Lance E. Rosenzweig and Quality Systems, Inc., No. SACV14-00110-DOC-JPPx, by Timothy J. Foss, a shareholder of the Company. The complaint arises from the same allegations described above related to the “complaints filed by Mr. Hussein” and the Deerfield Beach Police Pension Fund and generally alleges breach of fiduciary duties, abuse of control and gross mismanagement by the Company’s directors, in addition to unjust enrichment and insider selling by individual directors. The complaint seeks compensatory damages, restitution and disgorgement of all profits, court costs, attorneys’ fees and implementation of enhanced corporate governance procedures. The parties have agreed to stay this litigation pending resolution of the Defendants' anticipated motion to dismiss the Federal Securities Class Action.

In addition to the above, we have experienced legal claims by customers regarding product and contract disputes and from time to time, claims by other third parties asserting that we have infringed their intellectual property rights. We believe that these claims, including those filed by Mr. Hussein, the Deerfield Beach Police Pension Fund and the shareholder derivative action, are without merit and intend to defend against them vigorously; however, we could incur substantial costs and diversion of management resources even if we are ultimately successful in the defense of such claims. Litigation is inherently uncertain and always difficult to predict. We refer you to the discussion of infringement and litigation risks in our “Item 1A. Risk Factors” section of our Annual Report.

ITEM 1A. RISK FACTORS

Our business is subject to many risks and uncertainties, which may materially and adversely affect our future business, prospects, financial condition and results of operations. These risk factors are disclosed in “Item 1A. Risk Factors” in our Annual Report.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS



Exhibit Number	Description
31.1*	Certification of Principal Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**	XBRL Instance
101.SCH**	XBRL Taxonomy Extension Schema
101.CAL**	XBRL Taxonomy Extension Calculation
101.LAB**	XBRL Taxonomy Extension Label
101.PRE**	XBRL Taxonomy Extension Presentation
* Filed herewith. ** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of section 11 or 12 of the Securities and Exchange Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise is not subject to liability under these section.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



			QUALITY SYSTEMS, INC.
Date:	July 28, 2014	By:	/s/ Steven T. Plochocki
			Steven T. Plochocki
			Chief Executive Officer (Principal Executive Officer)

Date:	July 28, 2014	By:	/s/ Paul A. Holt
			Paul A. Holt
			Chief Financial Officer (Principal Accounting Officer)